Sacituzumab Govitecan In TNBC

Clinical trial NCT04230109 · RECRUITING

Trial details

NCT number: NCT04230109
Sponsor: Massachusetts General Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Invasive Breast Cancer Triple Negative Breast Cancer ER-Negative Breast Cancer PR-Negative Breast Cancer HER2-negative Breast Cancer

Start date: 2020-07-14
Primary completion: 2028-10-01
Enrollment: 239

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.